Cardiovascular benefits related to the use of SGLT-2 protein inhibitor drugs. Research, Society and Development, [S. l.], v. 13, n. 3, p. e10113345349, 2024. DOI: 10.33448/rsd-v13i3.45349. Disponível em: https://ojs34.rsdjournal.org/index.php/rsd/article/view/45349. Acesso em: 28 jun. 2025.